FMP
Agentix Corp.
AGTX
PNK
Inactive Equity
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
0.0322 USD
0.0001 (0.311%)
About
ceo
Mr. Salman Hoda
sector
Healthcare
industry
Biotechnology
website
https://www.agentixcorp.com
exchange
PNK
Description
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
CIK
0001603345
ISIN
US00848A1034
CUSIP
00848A103
Address
32932 Pacific Coast Highway
Phone
321 299 2014
Country
US
Employee
N/A
IPO Date
Aug 21, 2015
Summary
CIK
0001603345
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
00848A103
ISIN
US00848A1034
Country
US
Price
0.03
Beta
-1.5
Volume Avg.
1.29k
Market Cap
1.29M
Shares
-
52-Week
0.0301-0.129
DCF
-0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.07
P/B
-
Website
https://www.agentixcorp.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AGTX News
It looks like there's no news available.
